Stock Information
Alto Neuroscience Inc (ANRO)
Ticker Symbol: ANRO
Exchange: NYSE
Sector: Pharmaceuticals
Market Cap: $864.77 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -2.45
Revenue (TTM): $0.00 M
Dividend Yield: N/A
ROE: -47.22%
Latest News
-
HC Wainwright & Co. Maintains Buy on Alto Neuroscience, Raises Price Target to $55
Mon, Aug 17, 2026 12:16 PM
-
Alto Neuroscience (ANRO) Reports Another Quarterly Loss, Is The Stock Already Overvalued?
Sun, Aug 16, 2026 8:07 PM
-
Are Alto Neuroscience’s (ANRO) Rising Losses Funding a Stronger Depression Pipeline or Diluting Discipline?
Sun, Aug 16, 2026 8:08 AM
-
Alto Neuroscience (ANRO) Stock Looks Stretched On Expanded ALTO 207 Plans
Sun, Aug 16, 2026 3:16 AM
Key Financials
Financial data not available
